Expanded Activated Lymphocytes (EAL) as Adjuvant Therapy in Patients With HCC at High Risk of Recurrence After Radical Resection

NCT05213637 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

430

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

BIOLOGICAL: Expanded Activated Lymphocytes (EAL)
PROCEDURE: transarterial chemoembolization (TACE)

Sponsor

Chinese PLA General Hospital

Collaborators

[object Object]